Macular Degeneration Clinical Trials

A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Mobile Alabama

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Mobile Alabama 36608

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Arizona

UPDATED

Gilbert Arizona 85296

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Phoenix Arizona 85014

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Phoenix Arizona 85021

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Phoenix Arizona 85020

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

View More ▼

UPDATED

Springdale Arizona 72764

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Tucson Arizona

A clinical research study of X-82, Aflibercept and Placebo

UPDATED

Tucson Arizona 85710

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Gilbert Arizona 85295

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Phoenix Arizona 85014

A clinical research study of Ranibizumab ITV injection and Ranibizumab through RPDS Implant for the treatment of Age-Related Macular Degeneration

Phoenix Arizona 85020

A clinical research study of Ranibizumab ITV injection and Ranibizumab through RPDS Implant for the treatment of Age-Related Macular Degeneration

Phoenix Arizona 85014

A clinical trial seeking patients for a research study of OPT-302 and Lucentis™

Phoenix Arizona 85014

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Phoenix Arizona 85020

A clinical trial to evaluate treatments using RG7716 and Ranibizumab for patients with Age-Related Macular Degeneration (AMD), Choroidal Neovascularization

Phoenix Arizona 85012

A clinical trial to evaluate treatments using RG7716 and Ranibizumab for patients with Age-Related Macular Degeneration (AMD), Choroidal Neovascularization

Phoenix Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Phoenix Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Phoenix Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Phoenix Arizona 85021

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Phoenix Arizona 85020

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Phoenix Arizona 85014

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Phoenix Arizona 85014

A Phase 3 clinical study for patients with Geographic Atrophy

Phoenix Arizona 85020

A Phase 3 clinical study for patients with Geographic Atrophy

Tucson Arizona 85704

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Tucson Arizona 85710

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Tucson Arizona 85704

A clinical trial to evaluate treatments using RG7716 and Ranibizumab for patients with Age-Related Macular Degeneration (AMD), Choroidal Neovascularization

Tucson Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Tucson Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Tucson Arizona 85704

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Arkansas

Springdale Arkansas 72764

A clinical trial to evaluate treatments using No Intervention for patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima A)

California

UPDATED

Arcadia California 91007

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Arcadia California 91006

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Beverly Hills California

A clinical research study of X-82, Aflibercept and Placebo

UPDATED

Campbell California 95008

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Encino California 91436

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

View More ▼

UPDATED

Fullerton California 92835

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Glendale California 91203

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Glendora California 91741

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Huntington Beach California

A clinical research study of X-82, Aflibercept and Placebo

UPDATED

Huntington Beach California 92647

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Irvine California 92697-4375

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Loma Linda California 92354

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Long Beach California 90807

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Los Angeles California 90033

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration